June 2 (Reuters) - Shares of Fulcrum Therapeutics plunged 50% in premarket trading on Tuesday after the company said it would ...

Shares fell sharply after the biotech said some patients developed cancer in a late-stage clinical trial for the ...

The CRL comes after the FDA accepted the NDA for review in October 2025 and set a Prescription Drug User Fee Act target ...

Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...

Low dose of quetiapine (Seroquel) - frequently prescribed off-label for insomnia : Getty ImagesAmid growing concern about the ...

A series of recent FDA safety actions, drug recalls, label updates and court rulings across pharmacy carry operational implications for pharmacy leaders. The cases span product categories — from a ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

By Gianluca Lo Nostro June 2 (Reuters) - Abivax shares tumbled on Tuesday after the French biotech reported late-stage data for its experimental inflammatory bowel drug, with investors focusing on ...

Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's ‌new fast-track program after agency scientists flagged safety and ...

WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...